Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
Pharma's Almanac
PAO-07-23-RT-02Jul 21, 2023
FDA
DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CII
DURECT Corporation
PR-M08-18-NI-059Aug 15, 2018
Licensing Agreement
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR® (SABER®-Bupivacaine)
DURECT Corporation
PR-M05-18-NI-042May 10, 2018